Drug intelligence / Profile preview

Betusphere

Development stage
Preclinical
Lead developer
Artgen Biotech
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Nanoparticles → Drug Delivery Systems
Administration
Intramuscular
01

Overview

Betusphere is a recombinant protein vaccine candidate and immunomodulator developed by Artgen (formerly Human Stem Cells Institute). It is based on the proprietary Betusphere platform, which utilizes plant-derived betulin—a pentacyclic triterpenoid extracted from birch bark—to form spherical nanoparticle adjuvant particles. Recombinant protein antigens are adsorbed onto these betulin-based particles to create a stable vaccine complex designed to enhance and modulate immune responses. While the platform is employed in several of Artgen's infectious disease vaccine candidates (such as Betuvax-CoV-2 for COVID-19), this specific pipeline entry is being developed as a standalone immunomodulator. It is currently in preclinical development in Russia.

Other names
Betusphere platformBetusphere immunomodulator

Beyond the preview

Go deeper on Betusphere.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Betusphere.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call